Assertio Investor Relations Material
Latest events
Q2 2025
Assertio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Assertio Holdings Inc
Access all reports
Assertio Holdings Inc. is a pharmaceutical company focused on the development, marketing, and distribution of prescription medications. The company specializes in providing treatments for patients with chronic pain, neurological disorders, and other medical conditions. Assertio's portfolio includes a range of therapies aimed at improving patient quality of life, with an emphasis on non-opioid options for pain management. The company is headquartered in Lake Forest, Illinois, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ASRT
Country
🇺🇸 United States